Zobrazeno 1 - 10
of 141
pro vyhledávání: '"Tania Bubela"'
Publikováno v:
BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-18 (2023)
Abstract Background People with amyotrophic lateral sclerosis (ALS) face disability- and travel-related barriers to research participation. We investigate the usefulness and acceptability of asynchronous, online focus groups (AOFGs) for research invo
Externí odkaz:
https://doaj.org/article/51d6eeda43cf497cabfdd72fc573e8a5
Autor:
Dean A. Regier, Samantha Pollard, Melanie McPhail, Tania Bubela, Timothy P. Hanna, Cheryl Ho, Howard J. Lim, Kelvin Chan, Stuart J. Peacock, Deirdre Weymann
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-7 (2022)
Abstract Health technology assessment (HTA) can be used to make healthcare systems more equitable and efficient. Advances in precision oncology are challenging conventional thinking about HTA. Precision oncology advances are rapid, involve small pati
Externí odkaz:
https://doaj.org/article/668b42d8ee7f416e93fa39a68e3ca2b6
Autor:
Hannah L. Brooks, Ginetta Salvalaggio, Bernadette Pauly, Kathryn Dong, Tania Bubela, Marliss Taylor, Elaine Hyshka
Publikováno v:
Harm Reduction Journal, Vol 19, Iss 1, Pp 1-10 (2022)
Abstract Background Hospital patients who use drugs may require prolonged parenteral antimicrobial therapy administered through a vascular access device (VAD). Clinicians’ concerns that patients may inject drugs into these devices are well document
Externí odkaz:
https://doaj.org/article/f9eac229cffc49c7ab5e5a7e0aff9828
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background People with amyotrophic lateral sclerosis (ALS) are at high risk for severe outcomes from Covid-19 infection. Researchers exploring ALS and Covid-19 have focused primarily on system response and adaptation. Using Protection Motiva
Externí odkaz:
https://doaj.org/article/c7a9794d9fc24f9999e733472ca543f9
Autor:
Heather Morris, T Cameron Wild, Marina Giovannoni, Rebecca Haines-Saah, Jakob Koziel, Petra Schulz, Hauwa Bwala, Diane Kunyk, Tania Bubela, Elaine Hyshka
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0294608 (2023)
A growing body of evidence suggests that news media which includes a sympathetic portrayal of a mother bereaved by substance use can increase public support for harm reduction initiatives. However, the extent to which such news media coverage occurs
Externí odkaz:
https://doaj.org/article/95979e2e409048ff815a791ec87766ee
Publikováno v:
FACETS, Vol 6, Iss 1, Pp 403-423 (2021)
COVID science is being both done and circulated at a furious pace. While it is inspiring to see the research community responding so vigorously to the pandemic crisis, all this activity has also created a churning sea of bad data, conflicting results
Externí odkaz:
https://doaj.org/article/4ca19aa10e054fc6adcefb7896b1b217
Autor:
Tania Bubela, E. Richard Gold, Vivek Goel, Max Morgan, Karen Mossman, Jason Nickerson, David Patrick, Aled Edwards
Publikováno v:
FACETS, Vol 5, Iss 1, Pp 1019-1036 (2020)
In the event of the current COVID-19 pandemic and in preparation for future pandemics, open science can support mission-oriented research and development, as well as commercialization. Open science shares skills and resources across sectors; avoids d
Externí odkaz:
https://doaj.org/article/a93dfc176ad44d04aed60639ab60ebe7
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
International drug regulators use conditional drug approval mechanisms to facilitate faster patient access to drugs based on a lower evidentiary standard typically required of drug approvals. Faster and earlier access is justified by limiting eligibi
Externí odkaz:
https://doaj.org/article/b3b742157d414509bc37a80fbb8ad48b
Autor:
Stephanie P. Brooks, Tania Bubela
Publikováno v:
BMC Pediatrics, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Parents of children living with chronic but manageable conditions hope for improved therapies or cures, including Advanced Therapy Medicinal Products (ATMPs). Multiple pediatric clinical trials for ATMPs are underway, but the risk
Externí odkaz:
https://doaj.org/article/c8152bf00a4b43a3ba230ab5435285e6
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background Health care system decision makers face challenges in allocating resources for screening, diagnosis and treatment of hepatitis C. Approximately 240,000 individuals are infected with the hepatitis C virus (HCV) in Canada. Populatio
Externí odkaz:
https://doaj.org/article/5730db81eced4056bf1cdcf7f1304255